PAVmed Inc., a medical technology company, operating in the medical device, diagnostics, and digital health sectors, has announced that its majority-owned digital health subsidiary Veris Health Inc. has commercially launched its Veris Cancer Care Platform.
PAVmed-owned Veris Cancer Care Platform (CCP) is a digital cancer care platform with physiologic data collection, symptom reporting and telehealth functions, designed to improve personalized cancer care through remote patient monitoring.
Cancer patients enrolled in the Veris CCP program receive a VerisBox with Veris-branded bluetooth-enabled connected healthcare devices. The devices transmit clinical data to the cancer care team through the Veris CCP patient smartphone app and the cloud-based Veris CCP clinician portal.
The platform allows the cancer care team to detect early signs of common cancer-related complications, provide longitudinal trends of physiologic and clinical data, and offer data-driven risk management tools for precision oncology. The practice uses RPM codes to bill for the review and interpretation of clinical data.
Veris executed its first commercial contract with New Jersey Cancer Care.
Join the HealthXL Webinar on ‘Retail Healthcare: Current and Future Opportunities for Digital Health’ on 26th January. Click here to Request to Join.
Click here to read the original news story.